The first choice is pegylate berberine solution for preventing or reducing postoperative adhesion of abdominal (pelvic) cavity surgery

Pegylate berberine solution

Adhesions are the inevitable process of recovery of patients. Abdominal adhesions can cause obstruction, gynaecological adhesions lead to infertility, and orthopedic adhesions lead to dysfunction. Anti adhesion is closely related to the benign recovery of the patients. It is also the first of the most important complications in reducing the surgical trauma. The medical PEGylated Berberis solution has been in the market for 20 years, and the anti adhesion effect has been generally recognized by patients, surgeons and experts.

Pegylate berberine is a kind of three kinds of medical equipment product which is developed by academician expert workstation of Heilongjiang Liaoyuan Technology Co., Ltd. with national invention patent and clinical experiment.

[structure and composition] the composition of this product: polyethylene glycol 400, Berberis hydrochloride. The content of berberine hydrochloride: 1.5%. This product is a transparent and even liquid from yellowish to orange. Sterilized.

[scope of application] this product is used to prevent or reduce postoperative adhesion in abdominal (pelvic) cavity surgery.

[Mechanism] the medical pegylate has the barrier isolation function, reduces the formation of abnormal fibrin network, and effectively reduces the adhesion opportunity; It has the function of lubrication organization; It can inhibit capillary exudation, promote the production of epithelial cells and endothelial cells, inhibit fibroblast proliferation, reduce tissue adhesion, and facilitate tissue physiological repair; It can inhibit inflammatory exudation, promote absorption, reduce scar and reduce adhesion opportunity.

[contraindications] this product is only applicable for local use and cannot be injected intravenously.

[precautions] a) this product is sterile product, and aseptic operation shall be strictly implemented. The package is damaged and is forbidden to be used.

B) It is necessary to use it under sufficient hemostasis condition to prevent tissue adhesion, otherwise, the effect of use is reduced.

C) Joint swelling, joint cavity injection should be careful.

D) This product is disposable and cannot be reused.

The product is valid for two years, and it is forbidden to use it beyond the validity period.